Latest Pluripotency Stories
Ordinarily, embryonic stem cells exist only a day or two as they begin the formation of the embryo itself.
Can researchers predict the future of stem cells by knowing how they begin?
Investigators at the Massachusetts General Hospital (MGH) Center for Regenerative Medicine and the Harvard Stem Cell Institute (HSCI) have found that Sox2 – one of the transcription factors used in the conversion of adult stem cells into induced pluripotent stem cells (iPSCs) – is expressed in many adult tissues where it had not been previously observed.
Scientists have for the first time used a form of cloning to create personalized embryonic stem cells, an important advancement that could impact the study and treatment of diseases such as diabetes, Parkinson’s and Alzheimer’s.
Researchers at the University of California, Berkeley, have turned back the clock on mature muscle tissue, coaxing it back to an earlier stem cell stage to form new muscle.
Scientists have found a control switch that regulates stem cell "pluripotency," the capacity of stem cells to develop into any type of cell in the human body.
Ever since human induced pluripotent stem cells were first derived in 2007, scientists have wondered whether they were functionally equivalent to embryonic stem cells, which are sourced in early-stage embryos.
- totally perplexed and mixed up.